[Combination chemotherapy with nedaplatin and paclitaxel for ovarian cancer].
Yamamoto
Toshiya
T
Department of Gynecology, Osaka Medical Center for Cancer and Cardiovascular Diseases.
Morishige
Ken-ichirou
K
Ohta
Yukinobu
Y
Kamiura
Shoji
S
Saji
Fumitaka
F
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced; D016896:Treatment Outcome
D009944:Organoplatinum Compounds; C053989:nedaplatin; D017239:Paclitaxel